About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, although ...

"Connecticut is still perceived as a really great place to live," DataHaven Executive Director Mark Abraham said.

November 14, 2025 - About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy ...